Thaneswari Karpanasamy - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Thaneswari Karpanasamy

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Trends in Cancer|January 29, 2025

Cancer evolution: from Darwin to the Extended Evolutionary SynthesisThomas Savy, Lucy Flanders, Thaneswari Karpanasamy, et al.

Science Translational Medicine|April 16, 2025

Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemiaNicola Maciocia, Malika Hoekx, Ciaran Acuna, et al.

Blood|May 4, 2022

Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemiaPaul M Maciocia, Patrycja A Wawrzyniecka, Nicola C Maciocia, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Trends in Cancer|January 29, 2025

Cancer evolution: from Darwin to the Extended Evolutionary SynthesisThomas Savy, Lucy Flanders, Thaneswari Karpanasamy, et al.

Science Translational Medicine|April 16, 2025

Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemiaNicola Maciocia, Malika Hoekx, Ciaran Acuna, et al.

Blood|May 4, 2022

Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemiaPaul M Maciocia, Patrycja A Wawrzyniecka, Nicola C Maciocia, et al.

Pageof 1